Editorial & Research Team

Editors
Simone Fishburn, Ph.D.; Executive Editor, BioCentury and BioCentury Innovations

Simone serves as Executive Editor of Biocentury and BioCentury Innovations. She was previously Editor of BioCentury Innovations, and prior to that was a senior editor for SciBX: Science-Business eXchange, a joint publication between BioCentury and Nature Publishing Group. Simone also serves as an advisor on two university translational programs: the CTSI Catalyst program at the University of California San Francisco (UCSF) and the SPARK program at Stanford University. Prior to joining BioCentury in 2013, Simone spent nine years in preclinical drug development at Nektar Therapeutics, where she headed the Pain program as director of translational research, and two years at Exponent Inc., where she assisted small and large biotechs on a range of scientific projects. Before she entered the industry, Simone spent eight years in academia, first as a post-doc at UCSF and then performing research at the Weizmann Institute of Science. Simone is also active in programs to advance women's careers; she is a Board member of Women In Bio and served as president from 2013-2014. She is a Fulbright scholar, and holds a Ph.D. in molecular pharmacology from the Weizmann, and an M.A. and B.A. in pharmacology from Cambridge University.

Jeff Cranmer, Executive Editor, BioCentury Extra, and Head, News Group

Jeff serves as Managing Editor of BioCentury. Since joining BioCentury in 2005, Jeff has also been Editor of BioCentury Extra and head of BioCentury's Research Group. Jeff has an A.B. from Princeton University and an M.A. from the Johns Hopkins School of Advanced International Studies.

Susan Schaeffer, Editor Emeritus, BioCentury

Susan serves as Editor of BioCentury. She was previously Senior Editor in charge of Product Discovery & Development coverage from 2010 through 2012. She was Managing Editor of BioCentury and BioCentury Extra from 2004 through 2010. She joined BioCentury in 2003 after 10 years as an editor in the consumer packaged goods sector, including work with international strategy consultants Kurt Salmon Associates.

Senior Editors & Bureau Heads
Erin McCallister, Senior Editor, Head, Clinical Development & Market Access

Erin McCallister serves as senior editor for BioCentury where she is responsible for covering emerging issues in market access and reimbursement as well as innovative product development strategies, including novel clinical trial designs, patient-centered drug development and new methods for making R&D more efficient. Prior to joining BioCentury in 2008, Erin served as a program officer for the Great Lakes Protection Fund and a biologist at Dow AgroSciences. She holds an M. Sc. in environmental science and policy from the University of Chicago and a B.S. in biology from Purdue University.

Karen Tkach Tuzman, Ph.D., Associate Editor, Head, Discovery & Preclinical Research

Karen serves as BioCentury's head of preclinical and discovery content. She joined BioCentury in 2015 after a postdoctoral research fellowship in Stanford University's Department of Chemical and Systems Biology. Karen holds a Ph.D. in immunology from Weill Cornell Medicine and a B.A. in molecular and cell biology from the University of California Berkeley. 

Steve Usdin, Senior Editor (Washington), Head, Policy & Regulation

Steve has been Washington Editor of BioCentury since 1993, and has spent more than two decades in the nation's capital covering political and policy issues affecting the life sciences sector. He also is BioCentury Senior Editor responsible for coverage of social issues involving biotechnology, as well as the former host of BioCentury This Week, BioCentury's public affairs television program. Steve’s reporting about biotechnology and biomedical policy has been cited in The Economist, The Wall Street Journal, the Washington Post, New Scientist and other publications. In 2012, the FDA Alumni Association named Steve the Harvey W. Wiley Lecturer, making him the first journalist to receive the Wiley Award. He is the author of “Bureau of Spies: The Secret Connections between Espionage and Journalism in Washington” (Prometheus Books, 2018) and “Engineering Communism: How Two Americans Spied for Stalin and Founded the Soviet Silicon Valley,” (Yale University Press, 2005).

Associate Editors
Amy K. Goodwin, Ph.D., Associate Editor

Amy joined BioCentury in 2018 as an Associate Editor. Prior to spending five years as a behavioral pharmacology research scientist in a neurotoxicology division at the U.S. Food and Drug Administration, Amy was a faculty member in the division of behavioral biology at Johns Hopkins University School of Medicine, where she also completed her post-doctoral training. Amy holds a Ph.D. in the experimental analysis of behavior from Western Michigan University.

Michael J. Haas, Associate Editor

Mike joined BioCentury in 2007 after nearly 14 years as an analytical chemist and mass spectrometry group leader at DuPont, DuPont Merck, DuPont Pharma and Bristol-Myers Squibb. He holds an M.Sc. in chemistry from the University of Toronto and a B.S. in chemistry from the University of Delaware.

Stephen Hansen, Associate Editor

Stephen has been a writer and news editor for BioCentury since 2006. He holds B.A.s in biology and history from Bethel University and an M.Phil in history from Oxford University.

Selina Koch, Ph.D., Associate Editor

Selina joined BioCentury in 2014 after earning a Ph.D. in neuroscience and conducting postdoctoral research at the University of California San Francisco. Her experiments investigated the role of electrical and synaptic activity in forming organized and precisely tuned neural circuits during development. She also holds a B.S. in neurobiology and behavior from the University of Washington.

Meredith Durkin Wolfe, Associate Editor, Data & Analytics

Meredith joined the company as a Research Analyst and News Editor for both BioCentury Extra and BioCentury, Week in Review prior to becoming Research Manager for BioCentury. She has an A.B. in anthropology from the University of Chicago. Prior to BioCentury she worked in circadian rhythms research at Rush University and in market research with clients from a variety of industries.

Senior Writers
Emily Cukier, Senior Writer

Emily joined BioCentury in 2013 after gaining over six years of experience in the analysis and classification of clinical-stage drug products at Brand Institute. Previously, she conducted studies of protein folding at the University of Chicago and University of Cincinnati. She holds a B.S. in chemistry from Harvey Mudd College and an M.S. from the University of Chicago in biochemistry and molecular biology.

Michael Leviten, Ph.D., Senior Writer

Michael joined BioCentury in April 2016 as a senior writer for BioCentury Innovations. He brings with him 18 years of experience as an R&D scientist at biotech companies Deltagen Inc., Bayhill Therapeutics Inc. and Annexon Inc., where he focused on the development of biologic therapies for autoimmune and neurodegenerative diseases.

Lauren Martz, Senior Writer

Lauren joined BioCentury in 2007 as a research analyst in its research group. Lauren became a staff writer in 2008 as a member of the founding team of the SciBX: Science-Business eXchange publication launched between BioCentury and Nature Publishing Group, and advanced to senior writer for BioCentury Innovations in 2015. Lauren holds a B.S.E. in bioengineering from the University of Pennsylvania and an MBA from Temple University.

Staff Writers
Hongjiang Li, Ph.D., Staff Writer

Before joining BioCentury in 2016, Hongjiang worked as a research scientist at the Institute of Science and Technology in Austria, Ghent University and the University of California Riverside. She holds a Ph.D. in Biotechnology from Peking University, a P.P.M. in Bioscience Management from Keck Graduate Institute and a B.S. in Biotechnology from Sichuan University.

Virginia Li, Staff Writer

Virginia serves as a staff writer for BioCentury. Since joining BioCentury in 2014, Virginia has also been a staff writer and news editor for BioCentury Extra. She holds a B.A. in biology from Cornell University.

Winnie Pong, Ph.D., Staff Writer, Data & Analytics

Before joining BioCentury in 2016, Winnie was a medical writer at DynaMed and a postdoctoral fellow studying cancer neuroimmunology at Washington University Medical School in St Louis. She holds a Ph.D. in neurobiology from Boston University and a B.S. in biochemistry from the University of Massachusetts Amherst.

Mary Romeo, Staff Writer

Prior to joining BioCentury in 2015, Mary worked at the consulting firm Exponent Inc. for 10 years as a research specialist and health scientist, where her duties included code and literature research and managing and editing work product. She holds a B.S. in marine biology from the University of California Santa Cruz.

Mark Zipkin, Staff Writer

Mark joined the BioCentury Innovations team in 2014 following 11 years of editorial administration at Nature Publishing Group, where his duties included supporting SciBX: Science-Business eXchange, a joint publication from BioCentury and NPG. He holds a B.A. in English from Rutgers University and is the author of several screenplays and teleplays.

Copy Editor
Stephanie Goldman

Stephanie joined BioCentury in 2013 and currently serves as Copy Editor. She holds a B.A. in English and American studies and a minor in writing from the University of California Davis.